Key result
The host defense index (HDI), developed using 21 markers in an initial cohort of 32 patients and applied to 64 subsequent patients, successfully predicted operative mortality in esophageal cancer.
Why the study?
Does the host defense index (HDI) predict operative mortality and improve outcomes in patients with esophageal cancer?
Cohort (n=96)
Does the host defense index (HDI) predict operative mortality and improve outcomes in patients with esophageal cancer?
The host defense index (HDI) is a useful tool for predicting operative mortality risk in patients with esophageal cancer, allowing for tailored perioperative management.
May aid preoperative risk stratification in esophageal cancer; leaves open prospective validation before clinical adoption.
To determine whether operative risk based on impaired defense systems can be predicted, we examined 21 markers in 32 patients with esophageal cancer seen between 1983 and 1985 and related them to postoperative deaths. A discriminant analysis proved useful in determining whether the patient would be at risk of operative mortality, based on impaired defense systems. This model, the host defense index (HDI), was then used clinically to evaluate findings in 64 patients seen between 1986 and 1991. During this period, a change in policy for performing transthoracic esophagectomy on and perioperative care for patients with impaired defense systems was associated with a decrease in operative mortality. Thus, the HDI is beneficial to predict the risk of operative mortality based on impaired defense systems in patients with esophageal cancer.
No takes yet. Share an insight, caveat, or question.
Saito et al. (1993) conducted a cohort in Esophageal cancer (n=96). Host defense index (HDI) was evaluated on Operative mortality. The host defense index (HDI), developed using 21 markers in an initial cohort of 32 patients and applied to 64 subsequent patients, successfully predicted operative mortality in esophageal cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: